Loading Events

« All Events

  • This event has passed.

Shortening the Timeline for Developing New Treatments – How the Rare Disease Cures Accelerator – Data and Analytics Platform (RDCA-DAP) Can Help

June 24 @ 6:00 pm - 7:00 pm

Cambridge Rare Disease Network - Shortening the Timeline for Developing New Treatments - How the Rare Disease Cures Accelerator - Data and Analytics Platform (RDCA-DAP) Can Help 1
18 / 100

Shortening the Timeline for Developing New Treatments – How the Rare Disease Cures Accelerator – Data and Analytics Platform (RDCA-DAP) Can Help

by | May 27, 2020

in the National Organization for Rare Disorders (NORD®), Critical Path Institute (C-Path), and the US Food and Drug Administration (FDA) for an exclusive webinar on the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP). RDCA-DAP is an integrated database and analytics hub designed to build novel tools to accelerate drug development across rare diseases.

This webinar will explore why your organization should contribute to the RDCA-DAP, how to submit data, and how you can access and use the data and analytics platform. NORD, C-Path, and FDA will be available to answer specific questions about the project.

This webinar is appropriate for pharmaceutical, biotech, and medical device companies working in rare disease research and drug development, though all are welcome to join. Content will be of greatest interest to Chief Medical Officers, Heads of Clinical Development, Directors of Data Analytics, R&D, Data Science, Corporate Compliance, Corporate Affairs, and Advocacy.

Register for the FREE Webinar
Wednesday, June 24
2:00 – 3:00pm EDT

Webinar Speakers:

Cambridge Rare Disease Network - Shortening the Timeline for Developing New Treatments - How the Rare Disease Cures Accelerator - Data and Analytics Platform (RDCA-DAP) Can Help 3

Pamela Gavin, Chief Strategy Officer, National Organization for Rare Disorders

Cambridge Rare Disease Network - Shortening the Timeline for Developing New Treatments - How the Rare Disease Cures Accelerator - Data and Analytics Platform (RDCA-DAP) Can Help 4

Michelle Campbell, PhD, Sr. Clinical Analyst Stakeholder Engagement and Clinical Outcomes, FDA, Center for Drug Evaluation and Research

 

Cambridge Rare Disease Network - Shortening the Timeline for Developing New Treatments - How the Rare Disease Cures Accelerator - Data and Analytics Platform (RDCA-DAP) Can Help 5

Jane Larkindale, DPhil, Executive Director, Rare Disease Cures Accelerator-Data and Analytics Platform and Duchenne Regulatory Science Consortium, Critical Path Institute

 

Cambridge Rare Disease Network - Shortening the Timeline for Developing New Treatments - How the Rare Disease Cures Accelerator - Data and Analytics Platform (RDCA-DAP) Can Help 6

Robert C. Alexander, MD, Vice President and Head, Global Clinical Science Neuroscience Therapeutic Area Unit, Takeda Pharmaceuticals International Co.

Funding for this webinar was made possible, in part, by the US Food and Drug Administration through grant U18 FD 005320. Views expressed in written materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does any mention of trade names, commercial practices, or organization imply endorsement by the United States Government.

Venue

Webinar
WP Feedback

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

CRDN sign up to newsletter

Sign up to our monthly newsletter packed with news & events. Join our thriving rare disease community.

 

You have Successfully Subscribed!